SCHEDULE 13G//SEC Filing
Keros Therapeutics, Inc. SCHEDULE 13G
Accession 0000902664-25-001043
CIK 0001230239other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:12 PM ET
Size
11.1 KB
Accession
0000902664-25-001043
Documents
Issuer
ALKEON CAPITAL MANAGEMENT LLC
CIK 0001230239
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001230239
Filing Metadata
- Form type
- SCHEDULE 13G
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:12 PM ET
- Size
- 11.1 KB